A study has found that twice-daily stimulation of the vagus nerve with the hand-held gammaCore non-Invasive Nerve Stimulation (nVNS) device has reduced the number of headaches days per month from 14.7 to 8.9 (p<0.001) days per patient. The number of monthly migraine attacks observed was reduced from 7.3 to 4.5 (p<0.0001).
vasopharm Gmbh has raised €20 million of new capital, which it intends to use to fully fund a pivotal, European phase III study of its product, VAS 203, in patients with moderate-to-severe traumatic brain injury.
In the last year, five prospective randomised clinical trials have demonstrated the superiority of endovascular thrombectomy over medical management for the treatment of acute ischaemic stroke.
Endovascular coiling has made a huge impact on the treatment of intracranial aneurysms. Since the advent of the GDC coil 25 years ago, there has been growing body of evidence that support its use over surgical clipping in subarachnoid haemorrhage, and consequently its popularity has grown in the treatment of unruptured aneurysms as well. Now, more aneurysms than ever before are being coiled and volumes will increase further as coil and catheter technology continues to improve.
Neuravi has announced commercial availability of the company’s EmboTrap Revascularisation Device for the treatment of acute ischaemic stroke in Europe. The device will be marketed through the sales and distribution network the company has established in Belgium, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, Norway, Spain, Sweden and Switzerland.
Now that the safety and efficacy of mechanical thrombectomy for the treatment of acute ischaemic stroke has been proven in at least five randomised controlled trials, there is some worry within the community that the pressure to deliver this therapy to all appropriate patients will result in inexperienced operators attempting to do the procedures. But who are the ideal operators?
The Barrel Vascular Reconstruction device (Medtronic) is one of the newest offerings for the treatment of intracranial bifurcation aneurysms. Since receiving the CE mark in January of 2014, the device has been used throughout Europe. Now, Tufail Patankar (Consultant Interventional Neuroradiologist, Leeds Teaching Hospitals NHS Trust, Leeds, UK) speaks to NeuroNews about his experience with the Barrel vascular reconstruction device in his own practice, and explains why there is almost no learning curve associated with its use.
During a presentation at the European Society of Minimally Invasive Neurological Therapy annual meeting (ESMINT; 10–12 September, Nice, France) Jens Fiehler (director of the Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany) said that with the changes made to visibility and vessel wall apposition from Enterprise to Enterprise 2 (Codman Neuro), the problems with the older generation device have been solved.
Decreases in the benefits of intra-arterial clot-busting treatment, as well as a reduced chance for a good outcome, have been associated with delays in restoring blood flow after a stroke, according to an article published online by JAMA Neurology.
The world’s first Clot Summit has been held in Heidelberg, Germany. The meeting was chaired by Werner Hacke, a senior professor of Neurology at the University of Heidelberg Medical School.
InspireMD has received a DEKRA medical device certification for the manufacture and commercialisation of its CGuard delivery catheter.
The European Diagnostics Manufacturers Association (EDMA) and the European Medical Technology Industry (Eucomed) have approved a new joint code of conduct that stipulates that, after 31 December 2017, industry should no longer provide direct “financial or in kind support” to individual healthcare professionals to cover the costs of them attending third-party medical conferences. However, the new code does say that industry can provide educational grants to healthcare organisations to enable them to pay for physicians to attend conferences.
A study published in Circulation has shown adults with congenital heart defects to have much higher rates of stroke, compared to the general population.
Thomas Liebig (Berlin, Germany) reported that a first-line aspiration approach with MicroVention’s Sofia (soft torqueable catheter optimised for intracranial access) device is “worth a try” because it is associated with similar results to first-line aspiration approaches with other dedicated intermediate catheters, and unsuccessful aspiration with Sofia can be “easily converted” into stent retriever-based therapy.
In the Journal of NeuroInterventional Surgery (JNIS), Tufail Patankar (Department of Neuroradiology, Leeds Teaching Hospital, Leeds, UK) and colleagues present the first clinical report on the use of the Comaneci device (Rapid Medical) for the treatment of cerebral aneurysms. In the three-case experience, the investigators found that the Comaneci device can be used to achieve good cerebral aneurysm occlusion, while providing similar benefits to balloon remodelling but alleviating the associated time constraints.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos